We are spending more money than ever to find and treat cancer—some $100 billion in direct treatment costs alone.
Today, one subsidiary of the global chemical firm Industrial Chemicals, Inc., makes a number of cancer-causing pesticides, such as atrazine—a compound banned in much of the industrial world—while another division of ICI, AstraZeneca, produces tamoxifen, one of the most widely prescribed cancer drugs in the world.
Could this paradoxical strategy have anything to do with the fact that both the incidence of cancer not tied to smoking and its treatment options keep steadily increasing, while efforts to restrain environmental causes of the disease remain stymied?
This quote remains anonymous to protect the author.
Shop by Health Concern
Shop by Symptom
Shop by Brand